NCT06897293 Comparison of MBR + Suture Tape and MBR for CLAI : A Prospective Cohort Study
| NCT ID | NCT06897293 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Third Hospital |
| Condition | Ankle Sprain |
| Study Type | OBSERVATIONAL |
| Enrollment | 86 participants |
| Start Date | 2021-06-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 86 participants in total. It began in 2021-06-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
GJL is a risk factor for postoperative recurrent instability following an MBR for CLAI. Additional suture tape augmentation has been suggested to provide more strength and stability. However, the outcomes of the MBP with suture tape augmentation were unknown, which requires further exploration.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of lateral ankle instability * Beighton score ≥4 * Age with 18 to 60 years Exclusion Criteria: * Patients with an acute or subacute ankle injury * Injury of the deltoid ligament * Alignment of lower extremity greater than 5 degrees * Fractures of the lower extremity * Stage III or IV osteoarthritis * Patients who refused to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06897293 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 55 Years, studying Ankle Sprain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06897293 currently recruiting?
Yes, NCT06897293 is actively recruiting participants. Contact the research team at bysyjiangdong@126.com for enrollment information.
Where is the NCT06897293 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06897293 clinical trial?
NCT06897293 is sponsored by Peking University Third Hospital. The trial plans to enroll 86 participants.